Formulating, a key part of the pharmaceutical value chain, is a ‘make or break’ step in developing an active pharmaceutical ingredient (API) into a viable product. Formulators actively research, design, and iterate formulations that ensure the stability and efficacy of APIs, improve patient compliance with treatment regimen, and adhere to changing regulatory requirements. Without a strategic and intelligent formulating process, an API would never make it into the market.

Here, we discuss how pharmaceutical companies can maximize the strategic value of formulations data to shorten development timelines, stay ahead of competition and position themselves for success. Providing formulators with accurate and well-curated information can enable them to focus on innovating new formulation designs rather than spending time on repetitive, tedious activities.

https://www.cas.org/resources/whitepapers/formulations-data-value

Fuente: CAS, a division of the American Chemical Society

https://www.cas.org/resources/whitepapers/formulations-data-value
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

La exposición al frío y al calor duran...

El equipo de investigadores observó cambios en el...

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Un estudio preclínico mejora el tratami...

by CIMA - Centro de Investigación Médica Aplicada

Investigadores del Cima Universidad de Navarra constatan que la combin...

Diapositiva de Fotos